Savers Value Village (SVV) 10b5-1 sales and option disclosures by General Counsel

Rhea-AI Filing Summary

Richard A. Medway, General Counsel of Savers Value Village, Inc. (SVV) reported multiple insider transactions executed under a 10b5-1 plan. On 08/29/2025 he purchased 15,000 shares at $1.41 and concurrently sold 15,000 shares at a weighted-average price of $11.98, leaving 0 shares of common stock after that trade. On 09/02/2025 he purchased 17,500 shares at $1.41 and sold 17,500 shares at a weighted-average price of $12.5093, again resulting in 0 shares held following those trades. The filing also reports two stock option groupings exercisable into common stock: 15,000 options and 17,500 options exercisable at $1.41, and a reported total of 419,256 and 401,756 shares underlying options following the respective transactions.

Positive

• Sales executed under a recorded 10b5-1 plan (March 10, 2025) which provides procedural compliance and pre-clearance for trades
• Options and exercisable rights remain substantial, with 419,256 and 401,756 underlying shares reported after the transactions, showing alignment with incentive awards
• Disclosures include weighted-average sale prices and execution ranges, with the filer offering to provide per-price execution details on request

Negative

• After paired purchase and sale transactions on both dates, the reporting person held 0 shares of common stock, indicating no net accumulation of common stock holdings
• Significant insider sales at weighted-average prices of $11.98 and $12.5093 may be perceived by some investors as liquidity-taking by management

Insights

Financial Analyst

TL;DR: Insider executed matched buys and sales under a 10b5-1 plan, resulting in no net common stock holdings while retaining material option positions.

The reporting person executed purchases at $1.41 and contemporaneous sales at weighted-average prices of $11.98 and $12.5093 under a documented 10b5-1 plan. These transactions left 0 common shares held after each paired trade, while option positions remain sizable with 419,256 and 401,756 underlying shares reported post-transaction. For investors, this is a disclosure of liquidity activity by management rather than an operational update; it documents exercise/settlement activity and plan-based sales without showing accumulation of open common shares.

Corporate Governance Expert

TL;DR: Transactions follow a pre-established 10b5-1 plan and include option exercises previously granted under the company's incentive plan.

The filing explicitly states the sales were made pursuant to a 10b5-1 plan adopted March 10, 2025, and references options granted under the 2019 Management Incentive Plan that vested on scheduled terms. The report discloses vesting breakdowns for time-based and performance-based awards and confirms full vesting of a June 12, 2019 grant as of March 28, 2024. These disclosures align with required insider reporting and provide transparency on governance and compensation mechanics.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Medway Richard A.

(Last) (First) (Middle)

C/O SAVERS VALUE VILLAGE, INC.

11400 SE 6TH, SUITE 125

(Street)

BELLEVUE WA 98004

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Savers Value Village, Inc. [ SVV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	General Counsel

3. Date of Earliest Transaction (Month/Day/Year)
08/29/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/29/2025		M		15,000	A	$1.41	15,000	D
Common Stock	08/29/2025		S(1)		15,000	D	$11.98	0	D
Common Stock	09/02/2025		M		17,500	A	$1.41	17,500	D
Common Stock	09/02/2025		S(1)		17,500	D	$12.5093(2)	0	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option (Right to Purchase)(3)	$1.41	08/29/2025		M			15,000	(4)	06/12/2029	Common Stock	15,000	$1.41	419,256(5)	D
Option (Right to Purchase)(3)	$1.41	09/02/2025		M			17,500	(4)	06/12/2029	Common Stock	17,500	$1.41	401,756(6)	D

Explanation of Responses:

1. The sale was made pursuant to a 10b5-1 Plan adopted by the reporting person on March 10, 2025.

2. This price represents the weighted average price per share of common stock of Savers Value Village, Inc. These Shares were executed at a range of prices from $12.48 to $12.55. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.

3. Options previously granted under the Registrant's 2019 Management Incentive Plan. Each option represents the right to receive upon exercise one share of the Registrant's common stock subject to the applicable vesting and settlement conditions.

4. The June 12, 2019 stock option grant vested in substantially equal annual installments over five years starting March 28, 2020, and was fully vested on March 28, 2024.

5. Approximately 23% represents time-based options which vested in substantially equal annual installments over five years starting March 28, 2020, and approximately 77% represents performance-based options, of which 25% vested upon the initial public offering and the remainder will be eligible for vesting upon satisfaction of certain performance criteria including stock price performance.

6. Approximately 20% represents time-based options which vested in substantially equal annual installments over five years starting March 28, 2020, and approximately 80% represents performance-based options, of which 25% vested upon the initial public offering and the remainder will be eligible for vesting upon satisfaction of certain performance criteria including stock price performance.

Remarks:

	/s/ Richard Medway	09/03/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider trades did Richard Medway report for SVV?

The filing reports purchases of 15,000 shares on 08/29/2025 at $1.41 and sales of 15,000 shares at a weighted-average $11.98; and purchases of 17,500 shares on 09/02/2025 at $1.41 and sales of 17,500 shares at a weighted-average $12.5093.

Were the sales by the reporting person part of a prearranged plan?

Yes. The filing states the sales were made pursuant to a 10b5-1 plan adopted on March 10, 2025.

Does the filing show any common stock holdings after the reported trades?

No. After the reported paired transactions on each date, the reporting person is shown as holding 0 shares of common stock.

What option positions are disclosed in the Form 4?

The Form 4 discloses option rights exercisable at $1.41 covering 15,000 and 17,500 options and reports 419,256 and 401,756 underlying common shares beneficially owned following the respective transactions.

Were the options subject to vesting conditions?

Yes. The options were granted under the 2019 Management Incentive Plan and included time-based vesting over five years and performance-based vesting tied to IPO and other criteria, with a June 12, 2019 grant fully vested on March 28, 2024.